Detalhe da pesquisa
1.
T cell involvement in antiphospholipid syndrome.
Clin Immunol
; 263: 110218, 2024 Apr 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38640985
2.
The impact of traditional cardiovascular risk factor control on 7-year follow-up atherosclerosis progression in systemic lupus erythematosus.
Rheumatology (Oxford)
; 63(1): 50-57, 2024 Jan 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37086440
3.
Arterial stiffness tested by pulse wave velocity and augmentation index for cardiovascular risk stratification in antiphospholipid syndrome.
Rheumatology (Oxford)
; 63(4): 1030-1038, 2024 Apr 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37294733
4.
7-year follow-up atherosclerotic plaque progression in patients with antiphospholipid syndrome versus diabetes mellitus and healthy controls.
Rheumatology (Oxford)
; 2024 Feb 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38321577
5.
Outcomes of COVID-19 Omicron variant in patients with rheumatoid arthritis: a nationwide Greek cohort study.
Rheumatology (Oxford)
; 63(4): 1130-1138, 2024 Apr 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37467059
6.
Mediterranean diet trajectories and 20-year incidence of cardiovascular disease: The ATTICA cohort study (2002-2022).
Nutr Metab Cardiovasc Dis
; 34(1): 153-166, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38007352
7.
Progression of subclinical atherosclerosis in ankylosing spondylitis: a 10-year prospective study.
Rheumatol Int
; 44(4): 643-652, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38349401
8.
Outcomes of COVID-19 re-infections: a single-center cohort of 167 patients with systemic rheumatic diseases.
Rheumatol Int
; 2024 Mar 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38548908
9.
Glucocorticoid discontinuation rate and risk factors for relapses in a contemporary cohort of patients with giant cell arteritis.
Rheumatol Int
; 44(4): 603-610, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38300269
10.
Food Compass Score predicts incident cardiovascular disease: The ATTICA cohort study (2002-2022).
J Hum Nutr Diet
; 37(1): 203-216, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37908110
11.
Augmented oxidative stress, accumulation of DNA damage and impaired DNA repair mechanisms in thrombotic primary antiphospholipid syndrome.
Clin Immunol
; 254: 109693, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37454866
12.
Treat to target in Behcet's disease: Should we follow the paradigm of other systemic rheumatic diseases?
Clin Immunol
; 246: 109186, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36410686
13.
Deregulated DNA damage response network in Behcet's disease.
Clin Immunol
; 246: 109189, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36400336
14.
Distinct innate and adaptive immunity phenotypic profile at the circulating single-cell level in Psoriatic Arthritis.
Clin Immunol
; 253: 109679, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37336253
15.
Raynaud phenomenon and microvasculopathy in systemic sclerosis: multi-modality imaging for diagnosis and evaluation.
Curr Opin Rheumatol
; 35(6): 324-333, 2023 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37582056
16.
Long-term effectiveness and persistence of ustekinumab and TNF inhibitors in patients with psoriatic arthritis: final 3-year results from the PsABio real-world study.
Ann Rheum Dis
; 82(4): 496-506, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36600178
17.
Whole blood transcriptome identifies interferon-regulated genes as key drivers in thrombotic primary antiphospholipid syndrome.
J Autoimmun
; 134: 102978, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36587511
18.
Cardiac magnetic resonance imaging before and after therapeutic interventions for systemic sclerosis-associated myocarditis.
Rheumatology (Oxford)
; 62(4): 1535-1542, 2023 04 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36083014
19.
Different COVID-19 outcomes among systemic rheumatic diseases: a nation-wide cohort study.
Rheumatology (Oxford)
; 62(3): 1047-1056, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35920774
20.
Meta-analysis of placebo-arm dropouts in osteoporosis randomized-controlled trials and implications for nocebo-associated discontinuation of anti-osteoporotic drugs in clinical practice.
Osteoporos Int
; 34(3): 585-598, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36596944